BB Biotech AG
General ticker "BBAGF" information:
- Sector: Financials
- Industry: Financial - Conglomerates
- Capitalization: $4.7B (TTM average)
BB Biotech AG follows the US Stock Market performance with the rate: 1.9%.
Estimated limits based on current volatility of 4.2%: low 71.35$, high 77.65$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-03-24, amount 2.78$ (Y3.66%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [55.33$, 86.21$]
- 2026-12-31 to 2027-12-31 estimated range: [52.99$, 83.19$]
Short-term BBAGF quotes
Long-term BBAGF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CHF0.00MM | CHF111.63MM | CHF587.06MM |
| Operating Expenses | CHF206.53MM | CHF27.23MM | CHF8.86MM |
| Operating Income | CHF-206.53MM | CHF84.40MM | CHF578.20MM |
| Non-Operating Income | CHF-0.00MM | CHF-8.45MM | CHF0.00MM |
| Interest Expense | CHF5.80MM | CHF4.98MM | CHF0.06MM |
| Income(Loss) | CHF-206.53MM | CHF75.95MM | CHF578.20MM |
| Taxes | CHF0.08MM | CHF0.05MM | CHF0.07MM |
| Net Income(Loss)* | CHF-206.61MM | CHF151.80MM | CHF1,156.27MM |
| Stockholders Equity | CHF2,323.22MM | CHF2,286.29MM | CHF2,778.78MM |
| Assets | CHF2,637.15MM | CHF2,407.40MM | CHF2,785.76MM |
| Operating Cash Flow | CHF218.28MM | CHF304.56MM | CHF309.14MM |
| Financing Cash Flow | CHF-220.21MM | CHF-305.20MM | CHF-203.19MM |
| Earnings Per Share** | CHF-3.77 | CHF2.77 | CHF21.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.